Literature DB >> 438873

Chemotherapy as an adjunct in the initial management of cerebellar medulloblastomas. A preliminary report.

J L Venes, S McIntosh, R T O'Brien, A D Schwartz.   

Abstract

Eight consecutive children with biopsy-proven cerebellar medulloblastoma were treated with a combination of whole neuraxis radiation and prolonged chemotherapy using vincristine and cyclophosphamide. There was no evidence of tumor recurrence in the follow-up period, which ranged from 16 months to 7 years and 8 months following diagnosis. Morbidity associated with this regimen has been infrequent and easily reversible.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 438873     DOI: 10.3171/jns.1979.50.6.0721

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  3 in total

1.  A long surviving case of recurrent medulloblastoma displaying effectiveness of ACNU/vincristine chemotherapy.

Authors:  M Miyagami; K Satoh; T Tsubokawa
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

2.  Combination chemotherapy with cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) in children with brain tumors.

Authors:  L J Ettinger; D Sinniah; S E Siegel; L S Fishman; H D Segall; D Soni; G A Bennetts; D H Schultz; D Raphael
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

3.  Treatment of medulloblastoma in children: long-term results following surgery, radiotherapy and chemotherapy.

Authors:  C Mazza; A Pasqualin; R Da Pian; E Donati
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.